Conmed (CNMD) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.92% |
| Dec 31, 2025 | 2.07% |
| Sep 30, 2025 | 1.90% |
| Jun 30, 2025 | 1.82% |
| Mar 31, 2025 | 2.56% |
| Dec 31, 2024 | 3.33% |
| Sep 30, 2024 | 3.45% |
| Jun 30, 2024 | 3.59% |
| Mar 31, 2024 | 3.91% |
| Dec 31, 2023 | 16.34% |
| Sep 30, 2023 | 17.05% |
| Jun 30, 2023 | 18.31% |
| Mar 31, 2023 | 18.37% |
| Dec 31, 2022 | 16.74% |
| Sep 30, 2022 | 15.32% |
| Jun 30, 2022 | 14.63% |
| Mar 31, 2022 | 7.51% |
| Dec 31, 2021 | 6.55% |
| Sep 30, 2021 | 7.42% |
| Jun 30, 2021 | 7.06% |
| Mar 31, 2021 | 7.40% |
| Dec 31, 2020 | 22.72% |
| Sep 30, 2020 | 24.31% |
| Jun 30, 2020 | 25.40% |
| Mar 31, 2020 | 24.92% |
| Dec 31, 2019 | 26.07% |
| Sep 30, 2019 | 26.21% |
| Jun 30, 2019 | 26.90% |
| Mar 31, 2019 | 27.52% |
| Dec 31, 2018 | 16.21% |
| Sep 30, 2018 | 15.41% |
| Jun 30, 2018 | 13.92% |
| Mar 31, 2018 | 15.20% |
| Dec 31, 2017 | 24.62% |
| Sep 30, 2017 | 24.57% |
| Jun 30, 2017 | 24.20% |
| Mar 31, 2017 | 20.87% |
| Dec 31, 2016 | 28.28% |
| Sep 30, 2016 | 23.31% |
| Jun 30, 2016 | 24.32% |
| Dec 31, 2015 | 6.72% |